Verdict: Side-by-side breakdown using the Bull Rankings model. STWD scored 60.0, AGNC scored 71.0 — AGNC leads.
Compare another set
STWD
Starwood Property Trust, Inc.
REIT - Mortgage · Financial strength
64.9Fin
$12.48 · $4.7B
fundamentals as of
Strength gap
10.4
AGNC leads
AGNC
AGNC Investment Corp.
REIT - Mortgage · Financial strength
75.3Fin
$8.61 · $10.2B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
Fastest growthAGNC+84.7%
Strongest balance sheetSTWD3.31
Side by side · every name on one set of axes
Fundamentals, head-to-head
STWD
AGNC
15.1%C+
Yield
16.6%C+
-13.8%D
Rev
+84.7%A
3.31C
D/E
7.17D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
STWDStarwood Property Trust, Inc.
REIT - Mortgage · $12.48 · beta 1.05
Why now
REIT - Mortgage · market cap $4.7b. Down 35% from 52-week high of $19.06 — deep drawdown territory. Revenue -14% — in contraction; any catalyst that reverses this triggers re-rating. 8 sell-side analysts rate this a Buy with a mean 1-yr target of $19.56 (implying +57% upside).
Moat
Net margin 38% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
D/E 3.31 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Revenue contracting -14% — the operational turn is not yet visible in the top line. Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
AGNCAGNC Investment Corp.
REIT - Mortgage · $8.61 · beta 1.34
Why now
REIT - Mortgage · market cap $10.2b. Down 29% from 52-week high of $12.19 — deep drawdown territory. Revenue growing +85% — in hypergrowth territory. 9 sell-side analysts rate this a Hold with a mean 1-yr target of $10.61 (implying +23% upside).
Moat
Net margin 94% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 20% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 7.17 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Dividend payout 73% of earnings on a 16.6% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Common questions
Is AGNC or STWD the better stock?
AGNC scores higher: AGNC 71.0, STWD 60.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
How are AGNC and STWD scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.